Maine earns a B, ranking 24th of 51 states. That grade is accurate, and it conceals almost as much as it reveals.
The scorecard has genuine wins. Maine ranks fifth in the country on providers per capita, nearly double the rate in Alabama. Eight in ten adults get their annual checkup. Food insecurity is third-lowest in the nation. The uninsured rate, at 8.5%, beats the national average by nearly three points. Across the core health metrics, the state outperforms more than it underperforms.
Then you see the ER number. Maine sends its Medicare patients to emergency departments at a rate worse than 46 other states. Depression touches more than one in four adults, nearly five points above national. A state that's fifth in providers shouldn't be 47th in emergency care. That gap is where Maine's B starts to feel precarious.
The contradiction has a geographic address. Cumberland County, anchored by Portland, posts a death rate that rivals the best counties in the country. Washington County, two hours up the coast toward Canada, has a death rate more than twice as high. Maine's B is built on a fracture, not a foundation.
Start with the headline: Maine's death rate of 9,030 per 100,000 sits well below the national 10,368. That's 1,300 fewer deaths per 100,000 than the country as a whole. For a state of 1.4 million, that gap translates to thousands of lives. It's the state's most important number, and it's genuinely good.
The metrics that feed into it mostly point the same direction. Obesity runs at 33.8%, one in three adults, with all the cardiovascular disease, diabetes, and joint degeneration that implies, but below the national 37.5%. The diabetes rate (10.6%) is meaningfully below the national 12.4%, a sign that obesity hasn't yet fully converted to metabolic disease. That gap won't hold indefinitely, but it hasn't closed yet.
Smoking, inactivity, and drinking all run below national benchmarks. The uninsured rate, at 8.5%, beats the national 11.4%, the result of Medicaid expansion in 2019, after years of political resistance. Expanded coverage translates directly: roughly 119,000 fewer Mainers without insurance than the national rate would predict. That's why checkup rates are so high. Getting people covered gets them through the door.
Median household income of $67,106 edges above the national $65,754, an average doing heavy work in a state with serious county-level gaps. Child poverty (15.6%) runs below the national 19.4%, though even a relatively lower rate represents thousands of Maine children whose adult health trajectories are already being shaped by what they don't have now.
Mental health is where the good-news frame breaks. Nearly one in five adults (19.1%) reports fair or poor health, better than the national 21.3%. But depression affects 28% of Maine adults. That's nearly five points above national. More than one in four people in a state with long winters, high rural isolation, and a decade-long opioid crisis managing a depressive condition. The physical health indicators run ahead of the national curve. The mental health numbers run in the opposite direction, and that contradiction drives almost everything else in Maine's profile.
Maine's CDCDeviations chart tells a story about a system that invests heavily in finding problems and then runs out of capacity to solve them.
The prevention numbers are exceptional. Colorectal cancer screening runs more than five points above the national average. Mammography among women 50-74 is five points higher. Dental visits, checkups, food insecurity: Maine outperforms on nearly every measure of preventive engagement. The population shows up. That's not nothing.
But showing up and getting better aren't the same thing. Blood pressure medication adherence among those with high blood pressure sits at 65.7%, below the national 68.0%. The doctor found it. The prescription exists. Why doesn't the follow-through happen? That question runs through Maine's health data like a fault line.
Depression at 28% sits 4.5 points above the national average, the largest negative deviation in the state's health profile. Arthritis (30.3% vs. 27.2% nationally) tracks with an older population carrying more history of physical labor. Asthma runs two points above national. Food stamp usage (16.2%) exceeds the national 13.6%, a signal of economic precarity beneath the surface social indicators.
The pattern is consistent. Maine's screening apparatus works. The treatment side is where it frays.
Maine has 31,246 total providers serving 1.4 million people: 22.4 per 1,000 residents, fifth nationally. That's nearly double the rate in Alabama, which manages 11.1 per 1,000. The state runs 36 hospitals, 78 nursing homes, 21 dialysis facilities. By the numbers, Maine isn't underserved.
So where are all those providers? Look at what they are. The three largest specialties in Maine are clinical social workers (4,198), nurse practitioners (2,989), and mental health counselors (2,602). Family practice physicians number just 1,209. Maine doesn't have a physician shortage exactly; it has a physician replacement. Mid-level providers carry the primary care load in a state that can't attract or retain enough doctors. That's a practical adaptation. It's also a ceiling on what the system can deliver.
The shortage designations tell you where the ceiling hits hardest. Primary care shortages cover 239 designated areas. Dental shortages affect 250. Mental health shortages span 146 areas, covering a population of more than 3.6 million people. Counting providers statewide doesn't tell you where they actually practice, and in Maine, the answer is disproportionately Portland and the southern coast.
Then there's telehealth. Only 13.2% of CMS-enrolled providers offer telehealth services, worse than 33 other states and far below Massachusetts' 27.8%. For a state defined by geography, this isn't a missed opportunity. It's a failed one. A patient in Calais is three hours from Portland by car. Telehealth should be the frontline access tool for rural Maine. It isn't, and that failure compounds every shortage downstream.
Maine's Medicare patients go to the emergency room at a rate of 731.7 per 1,000, worse than 46 other states and well above Hawaii's 489.6. In a state that ranks fifth in providers per capita, that number demands an explanation.
Here's what makes it so strange: eight in ten Mainers see a provider annually. They're still ending up in emergency departments at alarming rates. The front door of the system is open. The rest of the building is harder to navigate.
The most plausible read: the annual visit finds the problem, but the follow-up doesn't happen. The specialist has a four-month wait. The mental health counselor isn't taking new patients. The dental emergency can't be handled at a primary care appointment. The prescription costs too much to refill. So the condition identified in January becomes the ER visit in March.
Maine's emergency utilization rate isn't primarily a story about how sick Mainers are. It's a story about what happens when a system finds problems it can't resolve, and patients wait until they can't wait anymore.
Maine's median household income of $67,106 edges above the national $65,754, but that single number is working hard for a state where Cumberland County sits at $96,255 and Washington County is at $48,104. The income inequality index of 4.42 captures the shape of that gap, not what it feels like to live at the bottom of it.
The uninsured rate (8.5%) is a genuine strength. Aetna leads the insurer market with 12,987 in-network providers, followed by Medicare (11,080), UnitedHealthcare (11,026), and Cigna (10,957). BCBS Massachusetts has a minimal footprint, mostly serving workers in the Portland metro with employment ties across the state line.
Drug spending reflects Maine's demographics directly. Total prescription claims run to 13.2 million on $2.27 billion in spending for 1.4 million people. Atorvastatin leads by volume (702,796 claims), the statin at the center of cardiovascular disease management. Levothyroxine (471,541 claims) and Lisinopril (464,608 claims) reflect thyroid disease and hypertension in an older population. Gabapentin (292,593 claims) sits high on the list: prescribed for nerve pain, but also widely used in managing opioid withdrawal in a state that has spent years fighting an overdose crisis.
The single most expensive drug is Apixaban: 271,592 claims totaling $284 million, roughly 12.5% of Maine's entire prescription drug bill. It's a blood thinner for atrial fibrillation patients. That one drug costs more than a quarter-billion dollars annually. It's as direct a statement as any about what Maine's aging demographics mean for its healthcare costs.
Maine's social determinants don't tell a simple story, and the radar chart reflects that.
Food insecurity at 12% is third-lowest in the country. Against Mississippi's 26.4%, the gap is more than 14 points. For a state without a dominant urban economic engine, that's a real achievement, built on food bank infrastructure, community ties, and a relatively lower cost of rural living. People here aren't going hungry at the rates seen elsewhere.
Housing insecurity (11.1%) sits below the national 13.2%. But food stamp usage (16.2%) exceeds the national 13.6%. That combination tells a specific story: incomes are precarious, programs are filling gaps that wages don't cover, and the margin between stability and crisis is thin.
What the radar chart can't fully show is distance. In Aroostook County, you're talking about a county larger than Connecticut and Rhode Island combined, one hospital in Presque Isle, and specialized care hours away. Rural Maine has social cohesion that gets missed in quantitative assessments: communities that look out for each other, networks built over generations. But cohesion can't drive someone to a psychiatrist, staff a dental clinic, or shorten a specialist's waitlist. A car breakdown, a job loss, a mental health crisis: in the northern counties, any of those can cascade quickly in places where the nearest resource is far away and full.
391 pharmaceutical companies made payments to 2,716 Maine providers last year, totaling $3.22 million across nearly 18,000 transactions. The average payment: $179.
That low average is the mechanism, not the exception. Consulting fees led by dollar value at $865,406 across 409 payments. Speaking and faculty compensation followed at $605,143. But the most frequent transaction type was food and beverage: 15,513 payments totaling $534,350. That's the rhythm of lunches and office visits and dinner meetings, one encounter at a time, building the relationship that the consulting fees formalize later.
At roughly $2.30 per resident, Maine's total pharma payments to providers are on the lower end nationally. And 2,716 paid providers out of 31,246 total means most Maine clinicians have no direct pharma financial relationship on record. The concern isn't saturation. It's concentration: a small group of providers receiving the bulk of payments, in a small state where those relationships carry more weight than they would in a larger market.
50 providers in Maine currently hold active exclusions from federal healthcare programs, 1.6 per 1,000 providers. These are practitioners the federal government has determined pose a risk to patients or to the integrity of Medicare and Medicaid billing. The historical figure of 633 includes providers whose exclusion periods have since ended.
Another 244 physicians have opted out of Medicare entirely: 7.8 per 1,000 CMS-enrolled providers. Opt-outs aren't inherently a red flag. Some providers shift to direct-pay or concierge models by choice. But in a state where 11,080 providers accept Medicare and where rural populations depend heavily on it, the geography of those opt-outs matters. If they're clustering in Portland and the coastal communities where affluent patients can pay cash, the practical result is a two-tiered system: concierge care for those who can afford it in the south, and Medicare-dependent access in the north. Maine doesn't publish where opt-outs cluster. It probably should.
Maine has 2,340 active clinical trials, ranking 49th in the country, worse than all but two other states. California runs 49,929. Even adjusting for population, Maine is dramatically underrepresented in the interventional research that gives patients access to emerging treatments.
NIH funding tells a different story. The state received $24.4 million across 29 awards, roughly $17 per capita, which ranks 14th nationally. Idaho receives about $1 per capita from NIH. The gap reflects real infrastructure: the University of Maine system, Maine Medical Center's research arm in Portland, and Jackson Laboratory in Bar Harbor, one of the world's leading genetics research institutions, are all punching well above their weight in securing federal funding.
The disconnect between 14th in NIH funding and 49th in clinical trials points to a specific pipeline failure. Maine generates research, primarily in basic science and genetics, but doesn't convert that into the interventional trials that enroll patients. The knowledge is being built here. It's just not reaching the people who could benefit from it.
Sagadahoc County's death rate of 5,914 per 100,000 is Maine's best. Twelve miles upriver from Portland, median income at $83,180, it benefits from the economic and healthcare ecosystem of Maine's largest city. Its death rate approaches the range of the healthiest counties in the country.
Washington County, on the Canadian border, has a death rate of 13,437. More than twice as high. Median income is $48,104; obesity runs at 40%. The 2.3-to-1 ratio between those two death rates is the most honest summary of Maine's health geography. It's not a statistic. It's a description of two different experiences of being alive in the same state.
Cumberland County (Portland) and York County anchor the southern corridor with incomes above $85,000 and death rates well below the national average. The midcoast, Lincoln County and Knox County, sits in similar territory despite lower incomes. Then there's everywhere else. Aroostook County, the state's largest by land area, posts a death rate above 10,500 on median income of $56,361. Penobscot County (Bangor) and Androscoggin County (Lewiston-Auburn) both carry 40% obesity rates and death rates above the national average, despite being Maine's second and third largest urban centers.
Geography isn't destiny in Maine. But the correlation between where you live and when you die is close enough that it might as well be.
The ER number is the one that won't let go. Fifth in providers per capita. 47th in emergency room utilization. No state should be able to achieve both rankings simultaneously. Maine does.
What that gap reveals isn't a system in failure. It's a system that works well at one thing and poorly at another. Maine gets people into healthcare: it has the providers, the coverage, the community engagement. What it can't do is resolve what it finds. Mental health treatment is chronically under-resourced. Telehealth adoption lags Massachusetts by 14 points, in a state where distance is the central barrier to follow-up care. Clinical trial access is nearly nonexistent. The front door is open. The rooms behind it are harder to reach.
Those problems have a geographic address. The investments that make the southern tier function, the hospitals, the specialists, the research infrastructure, don't reach Washington or Aroostook counties in any proportionate way. Maine's B is accurate for the state as a whole. For the northern counties, it's an aspirational grade applied to a different reality.
The state doesn't need more providers. It needs the ones it has to be reachable by the people who need them most. Until telehealth closes the distance, until mental health capacity catches up to mental health need, Maine will keep ranking fifth in access and 47th in outcomes. The inputs are there. The pipeline still leaks.